N-Benzylethylenediamine>97.0%(GC)5mL

4-bromo-1-(difluoromethyl)-3-methyl-1H-pyrazole, 95.0%, 1g

4-Iodoisoxazole, 95.0%, 250mg

6-Iodohex-1-yne, 95.0%, 1g

(S)-2-(4-Isobutylphenyl)propanoic acid, 98.0%, 100g

Methyl (S)-3-(4-bromophenyl)-3-((tert-butoxycarbonyl)amino)propanoate, 98%, 1g

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinolin-1(2H)-one, 97%, 5g

Methyl 5-hydroxymethyl-1-methyl-1H-pyrazole-3-carboxylate, 95.0%, 250mg

4,5-Dichloro-6-ethylpyrimidine, 95.0%, 250mg

2',3'-Dideoxyuridine>97.0%(HPLC)(qNMR)250mg

Methyl 3-bromo-4-(trifluoromethyl)benzoate, 95.0%, 1g

4-(2-thienyl)tetrahydro-2H-pyran-4-carbonitrile, 95.0%, 1g

Colonna capillare per GC ROTI®Cap-5, 50 m, 0,20 mm, 0,35 µm, 1 Pezzo(i)